Eterna Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eterna Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Eterna Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.53M, a 22.6% decline year-over-year.
  • Eterna Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$23.9M, a 10.1% decline year-over-year.
  • Eterna Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$21.7M, a 11.8% increase from 2022.
  • Eterna Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$24.6M, a 79.9% increase from 2021.
  • Eterna Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$123M, a 1581% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$21.7M +$2.91M +11.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$24.6M +$98M +79.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$123M -$115M -1581% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$7.29M -$5.24M -256% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
2019 -$2.05M -$1.79M -690% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$259K +$818K +76% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$1.08M +$1.85M +63.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 -$2.92M +$4.3M +59.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 -$7.23M -$2.2M -43.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-09
2014 -$5.03M -$3.98M -378% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 -$1.05M -$58K -5.83% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
2012 -$995K +$2.42M +70.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 -$3.42M -$3.02M -755% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-29
2010 -$400K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.